Dr. Connelly's clinical and research interests focus on transplant for non-malignant diseases and detecting and preventing long-term consequences of cancer and transplant therapy. He is a member of national research teams to improve transplant outcomes in patient with sickle cell, thalassemia, and immune deficiencies. Dr. Connelly also studies how to optimize the health status of BMT survivors. He is conducting research with the goal of developing strategies to avoid or overcome cardiac and neurocognitive complications in children who undergo BMT.
- Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL. MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol, 29: 4519-26, 2009.
- Muntean A, Tan J, Sitwala K, Yongsheng H, Bronstein J, Connelly JA, Venkatesha B, Elenitoba-Johnson K, Hess JL. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell, 17:609-21, 2010.
- Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol, 19:44-51, 2012.